DOJ

The Justice Department announced last week that pharmaceutical company Shire Pharmaceuticals LLC will pay $56.5 million to…

A whistleblower’s False Claims Act (FCA) suit in the Eastern District of California has caught the attention of the…

We outlined a special fraud alert that targeted the relationship between blood-testing laboratories and physicians. In…

In December 2013, we noted that the government has been increasingly using the False Claims Act (FCA) to combat fraud.…

A number of government attorneys have spoken at compliance conferences over the last year and noted that the days of…

March 20, 2014: The Supreme Court of Arkansas overturned a $1.2 billion judgment against Johnson & Johnson and its subsidiary,…

The U.S. recovered $4 billion last year through healthcare fraud prevention and enforcement efforts, according to a report…

Endo Health Solutions, Inc. and its subsidiary Endo Pharmaceuticals Inc. (Endo) have agreed to pay $171.9 million to resolve civil…

Recently at the CBI Pharmaceutical Compliance Congress a group of State, DOJ and US Attorneys thoroughly reviewed the life cycle…

U.S. Attorney for the District of Massachusetts, Carmen Ortiz, emphasized the importance of compliance programs early on during…